Dutch retail giant Ahold has said that the US Securities and Exchange Commission has launched an inquiry into accounting irregularities at Ahold and its US Foodservice unit.


The retailer revealed on Monday that accounting irregularities led to operating earnings for 2001 and 2002 being overstated by a total of at least US$500m. Ahold also announced the resignation of its CEO and CFO.


Since the announcement, Ahold’s share price has lost around 70% of its value, sparking some US law firms to file lawsuits on behalf of shareholders who have lost money during the collapse. Ahold has declined to comment on the lawsuits.


Meanwhile, the Dutch stock-market watchdog Autoriteit Financiele Markten (AFM) said it is looking into the issues surrounding the accounting irregularities following the collapse of Ahold’s stock.


However, the AFM said it was not conducting a formal investigation. “It’s logical that the AFM looks at stocks such as Ahold given the price developments,” spokesman Seger Pijnenburg was quoted by Dow Jones News as saying.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In a separate investigation, Pan-European bourse operator Euronext said it is looking into whether Ahold had complied with rules on the timely disclosure of information, reported Reuters.